Pancramin®citamins, natural peptides, Pancreatic bioregulator

Pancramin®

Pancreatic bioregulator
For pancreatitis, gastrointestinal disorders, and type 2 diabetes.
Recommended for improving pancreatic function, normalizing digestion and metabolic processes in the body.
Indications:
Pancramin Classic is indicated for various pancreatic disorders, such as:
– Acute pancreatitis;
– Chronic pancreatitis;
– Non-insulin-dependent diabetes;
– Gastrointestinal diseases with metabolic disorders;
– Pre- and postoperative periods after surgery on the gastrointestinal tract, pancreas, and duodenum;
– Elderly age (to maintain normal digestive function);
– Elderly individuals to maintain pancreatic cell function;

How to restore damaged pancreatic cells?

Of course, this depends on the mechanism and type of damage, requiring a tailored approach in each specific case. However, it can be said in general that almost all types of damage affect the protein structure of cells. This was established thanks to a discovery made in 1999 by Günter Blobel, who received the Nobel Prize for his research. He discovered that protein molecules are self-regulating. A deficiency of proteins and peptides (with age or due to damaging factors) accelerates tissue wear and tear, the aging process, and leads to the development of diseases.
For cells to regenerate and be protected from damage, they primarily require proteins. But each type of tissue contains specific types of proteins.

The components of Pancramin , derived from enzyme-endocrine raw materials, do not contain insulin and are represented by a complex of proteins and nucleoproteins with a specific, selective effect on the cellular structures of the human pancreas. This is because the protein and nucleoprotein complexes are identical in all mammals. Due to this, Pancramin  promotes the activation of restorative processes in pancreatic tissue and normalizes its digestive and hormonal functions.
Like all cytomins, Pancramin  acts specifically on pancreatic cells through transcytosis, promoting the normalization of their function.
Through transcytosis, the incoming protein reaches the target cell unchanged. In this case, the target is the pancreatic cells—the pancreatic cells. Upon reaching them, Pancramin  saturates them with an optimal protein “diet,” allowing the cells to recover more quickly and normalize their functions—the secretion of insulin and enzymes for normal digestion.

Clinical trials of Pancramin  were conducted in 125 patients with chronic pancreatitis and latent type 1 diabetes mellitus.
During a course of treatment with Pancramin , patients with chronic pancreatitis experienced increased appetite, a decrease in the frequency of dyspeptic symptoms, and an improvement in overall well-being. An increase in pancreatic enzyme activity (trypsin and amylase) was observed, consistent with positive clinical dynamics.
In patients with latent diabetes mellitus, Pancramin  was administered under the control of a glucose tolerance test. It was found that, with Pancramin , blood glucose levels gradually decreased and subsequently returned to normal.

How to take (course of administration and dosage):
1-3 tablets 2-3 times a day for 10-15 minutes before meals, drink water, do not chew. Course: 10-14 days. Repeated course after 3-6 months.
It is easily combined with other food additives and medicines.

Special instructions:
individual intolerance to the components.
Before use, it is recommended to consult with a specialist.

Ingredients: lactose, Pancramin® powder (from bovine pancreatic tissue), enteric coating Kollicoat MAE (copolymers of methyl methacrylate and methacrylic acid), potato starch, calcium stearate (anti-caking agent), propylene glycol (emulsifier).
Presentation and Package:
40 tablets per pack;
155 mg each tablet.